ISRCTN27244875CompletedNot Applicable
Randomised comparison of anticoagulation control and monitoring with versus without laboratory-provided computerized decision support
Ontario Program for Optimal Therapeutics (Canada)0 sites380 target enrollmentStarted: November 25, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 380
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Physicians:
- •1. Family or general practitioner
- •2. Full-time office practice
- •3. Practice address within study laboratory catchment area
- •4. At least 3 eligible patients willing to participate
- •1. On long-term warfarin therapy
- •2. Using the study laboratory for international normalized ratio (INR) tests and expecting to continue to do so for at least 12 months
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Assessing the correlations of anticoagulant effects between Thromboelastography [TEG] and anti-Xa activity in patients on therapeutic dose of low-molecular-weight heparin (LMWH)?Blood - Other blood disordersAcute coronary syndromeACTRN12609000055202Hayden White60
Recruiting
Not Applicable
Randomized study of anti-coagulant therapy to preventpostoperative deep venous thrombosis/pulmonary embolismPatients after diegstive surgery classified high risk in DVT/PE prevention guide lineJPRN-UMIN000002444unversity of tokushima, surgery300
Active, not recruiting
Not Applicable
Randomized evaluation of long term anticoagulant therapy (RELY)comparing the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel-group, non inferiority trial (RELY STUDY) - RELYprevention of stroke and systemic embolism in patients with non-valvular atrial fibrillationMedDRA version: 14.1Level: HLTClassification code 10000032Term: Cardiac conduction disordersSystem Organ Class: 100000004849EUCTR2005-003894-26-ITBOEHRINGER ING.15,000
Recruiting
Unknown
Comparative efficacy and safety of pill-in-the-pocket anticoagulation strategyDiseases of the circulatory systemKCT0008995Seoul National University Hospital400
Completed
Not Applicable
Evaluation of two models of delivering anticoagulant care to house bound patients in the community: a multidisciplinary studyISRCTN24180077Department of Health (UK)200